Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.09.12
中天堂富证券有限公司关于公司本次生意工业政策和生意类型之自力财务照料核查意见
2017.09.12
备考审阅报告(已作废)
2017.09.06
关于妄想刊行股份购置资产的停牌希望通告
2017.09.01
2017年第三次暂时股东大会决议通告
2017.09.01
2017年第三次暂时股东大会的执法意见书
2017.08.30
关于妄想刊行股份购置资产的停牌希望通告
2017.08.25
关于妄想刊行股份购置资产的停牌希望通告
2017.08.25
中天堂富证券有限公司关于公司重组停牌时代重组希望信息披露真实性、继续停牌合理性和6...
2017.08.23
关于妄想刊行股份购置资产的停牌希望通告
2017.08.19
关于增添2017年过活常谋划性关联生意预计金额的通告
第一页
上一页
67
68
69
70
71
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】